The aim of the study was to describe ECG modifications and arrhythmic events in COVID-19 patients undergoing hydroxychloroquine (HCQ) therapy in different clinical settings
Gasperetti, A., Biffi, M., Duru, F., Schiavone, M., Ziacchi, M., Mitacchione, G., et al. (2020). Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings. EUROPACE, 22(12), 1855-1863 [10.1093/europace/euaa216].
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings
Bellia, Alfonso;
2020-01-01
Abstract
The aim of the study was to describe ECG modifications and arrhythmic events in COVID-19 patients undergoing hydroxychloroquine (HCQ) therapy in different clinical settingsFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2020-europace-covid19-idrossiclorochina.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
555.11 kB
Formato
Adobe PDF
|
555.11 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
